Estimating Muscle Mass using D3-Creatine Dilution: A Narrative Review of Clinical Implications and Comparison with Other Methods

Abstract

Abstract Background The D3-creatine (D3-Cr) dilution method is of emerging interest for estimating total-body skeletal muscle mass. This review explores the association of muscle mass estimated via D3-Cr with various clinical outcomes and provides a summary of the literature comparing D3-Cr with other body composition techniques. Methods A literature search was conducted on PubMed/MEDLINE and Web of Science for studies using D3-Cr to measure muscle in adult populations (i.e., ≥18 years old) from inception until September 2023. Results Out of the 23 included studies, 15 investigated the correlation between D3-Cr and clinical outcomes. More consistent associations were reported for mortality (100%, n=2), mobility disability (100%; n=5), falls and fractures (100%; n=3), physical performance (63.3%; n=11), muscle strength (44.4%; n=9), and muscle composition (33.3%; n=3). However, conflicting findings were also reported for such correlations. Among the 23 studies, 14 compared D3-Cr-estimated muscle with other body composition techniques, including magnetic resonance imaging (MRI) as a reference method. Strong and positive correlations were found between D3-Cr and MRI. Nonetheless, variations in muscle measurements were noted, with differences in D3-Cr values ranging from 0.62kg lower to 13.47kg higher compared to MRI. Conclusions D3-Cr-estimated muscle mass may be a valuable predictor of clinical outcome showing consistent associations with falls and fractures, mobility disability, and mortality. However, less consistent associations were found with muscle strength and composition, and physical performance. Although a strong correlation exists between D3-Cr-estimated muscle mass and MRI measurements, under- or overestimation may occur.